A comprehensive view of Abbott Laboratories. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

INTERNATIONAL PATENT: ABBOTT LABORATORIES FILES APPLICATION FOR "BIOMARKERS AND METHODS FOR DIFFERENTIATING BETWEEN MILD AND SUPERMILD TRAUMATIC BRAIN INJURY"

INTERNATIONAL PATENT: ABBOTT LABORATORIES FILES APPLICATION FOR "HBV DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC METHODS AND PRODUCTS"

U.S. Patent and Trademark Office Receives Abbott Diabetes Care's Patent Application for Systems and Methods for Updating a Medical Device

Abbott Laboratories Climbs to No. 27 on Fortune's Most Innovative Companies List and Educates on Diabetes-Heart Disease Link, Reinforcing Its Industry Leadership

Abbott gets CE Mark approval for Bluetooth-enabled Assert-IQ insertable cardiac monitor in Europe; device offers the world's longest battery life and allows physicians to monitor patients' heart rhythms remotely for up to six years

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count